Medifast, Inc.

BMV:MED * Stock Report

Market Cap: Mex$4.0b

Medifast Past Earnings Performance

Past criteria checks 2/6

Medifast has been growing earnings at an average annual rate of 3.9%, while the Personal Products industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 10% per year. Medifast's return on equity is 14.3%, and it has net margins of 3.8%.

Key information

3.9%

Earnings growth rate

5.4%

EPS growth rate

Personal Products Industry Growth12.9%
Revenue growth rate10.0%
Return on equity14.3%
Net Margin3.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medifast makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BMV:MED * Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24770295315
31 Mar 24898685705
31 Dec 231,072996455
30 Sep 231,2181207135
30 Jun 231,3731337964
31 Mar 231,5301428975
31 Dec 221,5991449515
30 Sep 221,6391519824
30 Jun 221,6621579994
31 Mar 221,6031659594
31 Dec 211,5261649074
30 Sep 211,4131588374
30 Jun 211,2711507454
31 Mar 211,0971256443
31 Dec 209351035613
30 Sep 20841955093
30 Jun 20759764723
31 Mar 20726764553
31 Dec 19714784433
30 Sep 19689744232
30 Jun 19638723902
31 Mar 19568643492
31 Dec 18501563092
30 Sep 18433472692
30 Jun 18371402282
31 Mar 18330342022
31 Dec 17302281880
30 Sep 17286251772
30 Jun 17277241732
31 Mar 17273201682
31 Dec 16275181702
30 Sep 16273181673
30 Jun 16271171663
31 Mar 16272191692
31 Dec 15273201692
30 Sep 15274181670
30 Jun 15277181700
31 Mar 15279191710
31 Dec 14285211731
30 Sep 14267271570
30 Jun 14285271700
31 Mar 14307281870
31 Dec 13324272020

Quality Earnings: MED * has high quality earnings.

Growing Profit Margin: MED *'s current net profit margins (3.8%) are lower than last year (9.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MED *'s earnings have grown by 3.9% per year over the past 5 years.

Accelerating Growth: MED *'s has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MED * had negative earnings growth (-77.9%) over the past year, making it difficult to compare to the Personal Products industry average (8.6%).

Return on Equity

High ROE: MED *'s Return on Equity (14.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/30 20:44
End of Day Share Price 2024/07/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medifast, Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Kara AndersonB. Riley Securities, Inc.
Scott Van WinkleCanaccord Genuity